NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/02/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6.87 mln
Float0.98 mln
Earnings Date08/07/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
1.35
Highly suspicious
1-Year Forecast
30.00
Transformational upside
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
1.14
Elevated leverage
Dividend Yield
0.00%
No dividend
Business Description
HCW Biologics is a US-based drug development company focused on creating new treatments for diseases linked to aging and long-term inflammation. Founded in 2018 and based in Miramar, Florida, the company is advancing several experimental medicines through clinical trials, including therapies targeting solid tumor cancers, autoimmune conditions, and other age-related illnesses. It also holds partnership agreements with Wugen Inc. and WY Biotech to expand the reach of its treatment pipeline through shared research and licensing arrangements.
